A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy

Conclusions  Our study provides a proteomic atlas of the healthy and injured arterial wall that can be used to define novel factors for therapeutic targeting. We present TRPC6 as an actionable target to prevent neointima formation secondary to vascular injury and stent implantation.
Source: European Heart Journal - Category: Cardiology Source Type: research